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Background: Increased resting heart rate (RHR) independently predicts cardiovascular mortality. Mean-
while, long-chain n-3 fatty acids (LCn3FAs) have a cardioprotective effect. Our aim was to evaluate
whether higher LCn3FAs intake attenuates the elevated risk of cardiovascular mortality associated with
increased RHR.
Methods:Weconductedapopulation-based24-yearprospective cohort studyof Japanese,whoseLCn3FAs
intake is relatively high. Study participants included 8807 individuals aged 30–95 years from randomly
selected areas across Japan without cardiovascular diseases and anti-hypertensive drugs at baseline. The
primary endpoint was cardiovascular mortality, and the secondary endpoints were cardiac and stroke
mortality during 24 years of follow-up. Individual dietary LCn3FAs intakewas estimated fromhousehold-
based 3-day weighed food records. RHR was obtained from 3 consecutive R-wave intervals on 12-lead
electrocardiography. Cox models were used to estimate the multivariable hazard ratios (HRs) and 95%
conﬁdence intervals (95% CIs) adjusting for possible confounders.
Results:During the follow-upperiod, 617 cardiovascular deathswereobserved. Themediandaily intakeof
LCn3FAswas 0.37% kcal (0.86 g/day). The interaction between dietary LCn3FAs intake and RHR in the risk
of cardiovascular mortality was statistically signiﬁcant (p=0.033). The risk of cardiovascular mortality
was signiﬁcantly higher in the low-intake group (<0.37%kcal) with an RHR >85beats/min (bpm) [hazard
ratio (HR), 1.67; 95% conﬁdence interval (CI), 1.15–2.43], but not in the high-intake group (≥0.37%kcal)
with an RHR >85bpm (HR, 0.92; 95% CI, 0.61–1.38), compared with those in the high-intake group with
an RHR <70bpm. Similar results were observed with stroke mortality, but not with cardiac mortality.
∗ Corresponding author at: Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Setatsukinowa-cho, Otsu, Shiga 520-2192, Japan.
el.: +81 77 548 2191; fax: +81 77 543 9732.
E-mail address: hisataka@belle.shiga-med.ac.jp (T. Hisamatsu).
ttp://dx.doi.org/10.1016/j.jjcc.2014.01.005
914-5087/© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Conclusions: The risk of cardiovascularmortality associatedwith increased RHR is elevated in participants
with low dietary LCn3FAs intake, but not in participants with high dietary LCn3FAs intake in a represen-
tative Japanese general population. These results suggest that high dietary LCn3FAs intake may prevent
cardiovascular mortality associated with increased RHR.
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Multiple lines of evidence from epidemiological and clinical
tudies have shown that resting heart rate (RHR) independently
redicts cardiovascular mortality [1,2] in the general population
3,4] and in patients with cardiovascular diseases [5]. Based on
xperimental study results, several pathophysiological plausible
echanisms between increased RHR and cardiovascular systems
ave been proposed, including autonomic imbalance, acceler-
tion of atherosclerosis [6], induction of cardiac arrhythmias
7], progression of arterial stiffness [8], promotion of myocar-
ial oxygen consumption [9], and escalation of inﬂammation
10].
In vitro studies and animal experiments have examined the
ardioprotective effects of long-chain n-3 fatty acids (LCn3FAs)
11,12]. LCn3FAs directly reduce heart rate [13], and also favorably
ffect autonomic function [14], atherosclerosis [15], arrhythmo-
enicity [16], arterial wall compliance [17], myocardial oxygen
onsumption [18], and inﬂammatory pathways [19]. Each of these
ay contribute to a counteractive effect on the adverse cardiovas-
ular inﬂuence by increased RHR. Therefore, we hypothesized that
high LCn3FAs intake attenuates the elevated risk of cardiovascular
ortality associated with increased RHR in the general population
ree of cardiovascular diseases.
We tested this hypothesis in a 24-year prospective cohort study
f a representative Japanese general population who participated
n the National Survey of Circulatory Disorders and the National
utrition Survey of Japan. This community-based Japanese pop-
lation tends to have a higher LCn3FAs intake compared with
ther populationsworldwide [20], andwas therefore useful for this
nvestigation.
ethods
tudy participants
Cohort studies of the National Survey on Circulatory Disor-
ers and the National Nutrition Survey of Japan are known as the
ational Integrated Project for Prospective Observation of Non-
ommunicable Disease And its Trends in the Aged (NIPPON DATA).
e analyzed data from NIPPON DATA80 using a baseline survey
onducted in 1980. The detailed methods are described elsewhere
4,21,22]. The present study was approved by the Institutional
eview Board of Shiga University of Medical Science (No. 12-18,
000; No. 17-21-1, 2010).
Members of an overall population (n=13,771) aged ≥30 years
rom 300 randomly selected health districts throughout Japan
ere invited to participate in the study. Among them, 10,546
ommunity-based individuals (76.6%) agreed to join the study.
he survey consisted of a physical examination, blood test, self-
dministered questionnaire on lifestyle, dietary assessment, and
tandard 12-lead electrocardiography recording. For the present
tudy, participants were followed up to 2004 (NIPPON DATA80,
980–2004).
A total of 1739 participants were excluded from this analy-
is for the following reasons: history of cardiovascular diseases
n=280), missing baseline information (e.g. electrocardiography,anese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
RHR, or dietary data) (n=373), non-sinus rhythm (n=62), and anti-
hypertensive medication (n=1024). Therefore, 8807 participants
were ﬁnally included in the present analyses [4909 women; mean
(SD) age, 48.3 (12.8) years; range, 30–95 years].
End-point determination
To determine the cause of death during the 24-year follow-
up, the National Vital Statistics database of Japan was used with
permission from the Management and Coordination Agency, Gov-
ernment of Japan. The underlying causes of death in the National
Vital Statistics were coded according to the Ninth International
Classiﬁcation of Disease (ICD9) until the end of 1994, and accord-
ing to the Tenth International Classiﬁcation ofDisease (ICD10) from
1995 onwards, as described elsewhere [4].
The primary endpoint was cardiovascular mortality, and the
secondary endpoints were cardiac and stroke mortality occurring
during the follow-up period. The corresponding ICD9 and ICD10
codes were as follows: cardiovascular mortality, 393 to 459 (ICD9)
and I00 to I99 (ICD10); cardiacmortality, 393 to 429 (ICD9) and I01
to I09, I11, I13, and I20 to I52 (ICD10); and stroke mortality, 430 to
438 (ICD9) and I60 to I69 (ICD10).
Baseline dietary assessment
A dietary survey in each household was based on weighed
food records for 3 consecutive representative days, avoidingweek-
ends and holidays, by trained dietary interviewers. Dietary data
were processed centrally to calculate nutrients. The nutrient intake
reported for each household in the National Nutrition Survey of
Japan in 1980 was proportionally allocated to each household
member according to the mean consumption rate by age and sex.
Dietary researchers were blinded to the participants’ electrocar-
diographic and outcome status. For energy-supplying nutrients,
the intake was calculated as the percentage of total energy intake
(%kcal). Other nutrients were calculated relative to total dietary
intake (g/1000kcal).
The detailed calculation procedure and the validity of the
estimation have been described elsewhere [23–26]. Furthermore,
energy andmacronutrient intake among Japanese individuals esti-
mated using the same dietary assessment as in the present study
were highly correlated to corresponding values with individual-
based weighed food records (correlation coefﬁcients, 0.90–0.92)
[27].
Baseline RHR measurement
RHR was determined by a standardized assessment, which
is the measurement from 3 consecutive intervals between R
waves on 12-lead electrocardiography by trained technicians after
the participant rested quietly in the supine position for 5min.
Electrocardiographic measurements are described in more detail
elsewhere [4,21]. RHR and other electrocardiographic ﬁndings in
accordance with the Minnesota Code (MC) were independently
evaluated at a baseline survey by 2 trained researchers (blinded
to participant dietary and outcome status). Findings that showed
agreement between the 2 researchers’ assessments were accepted,
2 of Cardiology 64 (2014) 218–224
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Table 1
Baseline characteristics of 3898 men and 4909 women according to dietary long-
chain n-3 fatty acids intake: NIPPON DATA80, Japan, 1980–2004.
High-intake
(≥0.37%kcal)
Low-intake
(<0.37%kcal)
p-Value
n=4429 n=4378
Age (y)a 49.2 (12.8) 48.1 (12.8) <0.001
Women, n (%) 2581 (58.3) 2328 (53.2) <0.001
Smoking status, n (%) <0.001
Never 2625 (59.3) 2398 (54.8)
Ex- 356 (8.0) 435 (9.9)
Current 1448 (32.7) 1545 (35.3)
Alcohol drinker, n (%) 0.007
Never 2506 (56.6) 2339 (53.4)
Occasional 993 (22.4) 1023 (23.4)
Daily 930 (21.0) 1016 (23.2)
Body mass index
(kg/m2)a
22.6 (3.1) 22.5 (3.1) 0.056
Total cholesterol
(mg/dl)a
187.9 (33.3) 186.8 (33.0) 0.158
Blood glucose (mg/dl)a 99.8 (29.5) 98.6 (29.2) <0.001
Blood pressure (mmHg)a
Systolic 133.6 (19.9) 132.8 (19.4) 0.038
Diastolic 80.3 (11.7) 80.1 (11.7) 0.340
Labor intensity, n (%) 0.010
Low 1672 (37.8) 1759 (40.2)
Medium 1598 (36.1) 1587 (36.2)
High 1159 (26.2) 1032 (23.6)
Heart rate (beats/min)a 69.6 (11.1) 69.8 (11.4) 0.708
Electrocardiographic ﬁndings, n (%)
Left ventricular
hypertrophyb
654 (14.8) 639 (14.6) 0.821
Suspected coronary
heart diseasec
214 (4.8) 195 (4.5) 0.673
a Mean (standard deviation).
b Diagnosis of left ventricular hypertrophy was based on Minnesota Code 3.1 or
>85bpm) are shown in Supplementary Table 1 (Supplemental Dig-
ital Content 1).
The baseline nutritional parameters in both groups of partici-
pants are shown in Table 2. The mean dietary LCn3FAs intakes in
Table 2
Baseline nutritional variables of 3898 men and 4909 women according to dietary
long-chain n-3 fatty acids intake: NIPPON DATA80, Japan, 1980–2004.
High-intake
(≥0.37%kcal)
Low-intake
(<0.37%kcal)
p-Value
n=4429 n=4378
Total energy intake (kcal) 2121.7 (492.3) 2186.6 (486.8) <0.001
Vegetables (g/1000kcal) 133.9 (50.5) 126.6 (46.7) <0.001
Meat (g/1000kcal) 26.9 (15.9) 30.8 (15.8) <0.001
Fruit (g/1000kcal) 81.5 (56.2) 74.6 (51.5) <0.001
Fish (g/1000kcal) 63.8 (24.1) 37.6 (16.6) <0.001
Total n-3 fatty acids (%kcal) 1.34 (0.34) 0.96 (0.27) <0.001
Long-chain n-3 fatty acids
(%kcal)
0.59 (0.22) 0.24 (0.08) <0.001
-Linolenic acid (%kcal) 0.68 (0.26) 0.69 (0.25) <0.001
n-6 Polyunsaturated fatty
acids (%kcal)
4.27 (1.23) 4.38 (1.20) <0.001
Monounsaturated fatty
acids (%kcal)
7.83 (2.06) 7.78 (2.08) 0.600
Saturated fatty acids
(%kcal)
5.92 (1.53) 5.97 (1.60) 0.158
Total fat (% kcal) 20.6 (5.4) 21.2 (5.6) <0.00120 T. Hisamatsu et al. / Journal
nd ﬁndings that showed disagreement were adjudicated by a
anel of epidemiologists and cardiologists.
Electrocardiographic ﬁndings included Q wave abnormality
MCs 1.1–1.3), left ventricular hypertrophy (MCs 3.1–3.3), major
T depression (MCs 4.1–4.3), major T abnormality (MC 5.1 or 5.2),
omplete left bundle branch block (MC 7.1), and intraventricular
lock with a QRS duration ≥120ms, except for complete left or
ight bundle branch block (MC 7.4) [28].
tatistical analysis
First, participants were divided into 2 groups according to
edian dietary LCn3FAs intake (0.37%kcal: 0.86 g/day) as high
≥0.37%kcal) or low (<0.37%kcal) intake. Baseline characteristics
nd nutritional intake are presented as means and standard devi-
tions for continuous variables, and frequencies and percentages
or categorical variables. Differences in baseline characteristics and
utritional parameters were evaluated using the unpaired Stu-
ent’s t-test, Mann–Whitney U-test, or 2 test, as appropriate.
Cox proportional hazards models were used to estimate multi-
ariable adjusted hazard ratios (HRs) and 95% conﬁdence intervals
CIs) for each cardiovascular outcome according to 6 groups cross-
lassiﬁed by 2 categories of LCn3FAs (high- or low-intake) and 3
ategories of RHR [<70beats/min (bpm), 70–85bpm, and >85bpm]
s follows: high-intake groupwith anRHR<70bpm(the reference);
igh-intake group with an RHR of 70–85bpm; high-intake group
ith an RHR >85bpm; low-intake group with an RHR <70bpm;
ow-intake groupwith anRHRof 70–85bpm; and low-intake group
ith an RHR >85bpm. The choice of cutoff points of RHRwas based
n identical cutoff points in previous studies of RHR and cardiovas-
ular mortality [5,29].
To control potential confounders, multivariable models were
djusted for age, sex, body mass index, smoking status (never, ex-,
nd current), drinking habits (never, occasional, and daily), sys-
olic bloodpressure, total cholesterol, bloodglucose, labor intensity
high, medium, and low), electrocardiographic ﬁndings [30,31]
left ventricular hypertrophy classiﬁed according to MC 3.1 or 3.3,
nd suspected coronary heart disease classiﬁed according to MCs
.1–1.3, 5.1–5.2, 4.1–4.3, 7.1, or 7.4), and nutritional parameters
intake of saturated fatty acids, n-6 polyunsaturated fatty acids,
odium, and ﬁber). Tests for interaction between RHR and dietary
Cn3FAs intake were performed by introducing a multiplicative
nteraction term into the main models.
We performed the following sensitivity analysis. To take into
ccount the possibility of an effect by an unknown preclinical dis-
ase, we conducted a separate analysis where deaths within the
rst 5 years of follow-up were excluded. This exclusion was per-
ormedbydealingwith deathswithin theﬁrst 5 years as “censored”
4]. To assess interactions between RHR and other nutritional
ariables, we also analyzed the risk of cardiovascular mortal-
ty according to 6 groups cross-classiﬁed by 3 categories of RHR
<70bpm, 70–85bpm, and >85bpm), and 2 categories of low- or
igh-intake, including eicosapentaenoic acid (EPA), docosahexae-
oic acid (DHA), and ﬁsh intake.
All analyses were performed with SAS version 9.1.3 (SAS Insti-
ute, Cary,NC,USA). Allp-valueswere two-sidedandp-values <0.05
ere considered statistically signiﬁcant.
esults
The baseline characteristics of the 2 groups of participants
ccording to dietary LCn3FAs intake are shown in Table 1. Par-
icipants in the high-intake group tended to be older, have a
igher proportion of women, were more often never smokers and
ever alcohol drinkers, had higher blood glucose levels, had higher3.3.
c Suspicion of coronary heart disease was based on Minnesota Codes 1.1–1.3,
5.1–5.2, 4.1–4.3, 7.1, or 7.4.
systolic blood pressure, and were more likely to be labor inten-
sive compared with those in the low-intake group. The baseline
characteristics by 3 categories of RHR (<70bpm, 70–85bpm, andTrans fatty acids (%kcal) 0.31 (0.20) 0.37 (0.21) <0.001
Sodium (g/1000kcal) 2.74 (0.89) 2.41 (0.76) <0.001
Fiber (g/1000kcal) 8.53 (2.11) 8.34 (1.98) <0.001
Values are mean (standard deviation).
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he high- and low-intake groups were 0.59%kcal (1.38 g/day) and
.24%kcal (0.58 g/day), respectively. Participants in the high-intake
roup had higher intake of sodium, ﬁber, vegetables, fruit, ﬁsh, and
otal n-3 fatty acids than those in the low-intake group. In contrast,
articipants in the high-intake group had less total energy intake
nd had a lower intake of meat, -linolenic acid, n-6 polyunsatu-
ated fatty acids, total fat, and trans fatty acids comparedwith those
n the low-intake group. The baseline nutritional parameters by 3
ategories of RHR (<70bpm, 70–85bpm, and >85bpm) are shown
n Supplementary Table 2 (Supplemental Digital Content 2).
During the 24-year follow-up period [mean, 21.4 (5.5) years],
17 participants (7.0%) died from cardiovascular causes. Of these,
14 (3.6%) were from cardiac causes (121 from coronary heart dis-
ase, 1.4%) and 285 (3.2%) were from stroke (162 from ischemic
troke, 1.8%).
Fig. 1 shows the multivariable adjusted HRs and 95% CIs of
ardiovascular outcomes among the groups according to the 6
ategories cross-classiﬁed by LCn3FAs (high- or low-intake) and
HR (<70bpm, 70–85bpm, and >85bpm). The risk of cardiovascu-
ar and stroke mortality were signiﬁcantly elevated (adjusted HR,
.67; 95% CI: 1.15–2.43, and adjusted HR, 2.05; 95% CI: 1.24–3.37,
espectively), but the risk of cardiac mortality was not statistically
igniﬁcant (adjusted HR, 1.32; 95% CI: 0.74–2.38) in the low-intake
ig. 1. Hazard ratios and95% conﬁdence intervals of cardiovascular outcomes among grou
eart rate in 3898 men and 4909 women: NIPPON DATA80, Japan, 1980–2004. Adjusted
A), cardiac mortality (B), and stroke mortality (C) across 6 categories are shown. The hig
eference category. Filled circles and horizontal bars represent HRs and 95% CIs, respective
urrent), drinking habits (never, occasional, and daily), systolic blood pressure, total chole
ndings (left ventricular hypertrophy and suspected coronary heart disease), and nutrit
odium, and ﬁber).diology 64 (2014) 218–224 221
group with an RHR >85bpm compared with those in the high-
intake group with an RHR <70bpm. In contrast, in the high-intake
group with an RHR >85bpm, the risk of cardiovascular outcomes
was not signiﬁcantly elevated (adjusted HR, 0.92 for cardiovascu-
lar, 0.89 for stroke, and 0.98 for cardiac mortality). A multiplicative
interaction between RHR and dietary LCn3FAs intake in the risk of
cardiovascular and stroke mortality was statistically signiﬁcant (p
for interaction=0.033 and 0.026, respectively), but not in the risk of
cardiacmortality (p for interaction=0.410). Because further adjust-
ment for other nutritional parameters (e.g. total energy intake,
and intake of vegetables, fruit,meat,-linolenic acid,monounsatu-
rated fatty acids, total fat, and trans fatty acids) did not appreciably
change the results, we did not include these factors in the ﬁnal
model. Additionally, there was no evidence of a sex interaction
with 6 categories cross-classiﬁed by LCn3FAs and RHR for any of
the outcomes (p for interaction >0.2).
Results were not substantially altered in the sensitivity analy-
sis that excluded deaths within the ﬁrst 5 years of follow-up for
the risk of cardiovascular mortality (see Supplementary ﬁgure leg-
ends and Supplementary Figure 1, Supplemental Digital Content
3 and 4, respectively). In another sensitivity analysis according to
EPA or DHA intake, participants in the low-intake group with an
RHR >85bpm had a signiﬁcantly elevated risk of cardiovascular
ps according to 6 categories cross-classiﬁed by long-chain n-3 fatty acids and resting
hazard ratios (HRs) and 95% conﬁdence intervals (CIs) for cardiovascular mortality
h-intake group with a resting heart rate (RHR) <70beats/min (bpm) served as the
ly. HRswere adjusted for age, sex, bodymass index, smoking status (never, ex-, and
sterol, blood glucose, labor intensity (high, medium, and low), electrocardiographic
ional parameters (intake of saturated fatty acids, n-6 polyunsaturated fatty acids,
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ortality (adjusted HR, 1.57 for EPA; 1.64 for DHA) compared with
hose in the high-intake group with an RHR <70bpm. In contrast,
articipants in the high-intake groupwith an RHR >85bpm did not
ave a signiﬁcantly elevated risk (adjustedHR, 1.00 for EPA; 0.96 for
HA) (p for interaction between RHR and LCn3FAs intake: 0.034 for
oth) (seeSupplementaryﬁgure legendsandSupplementaryFigure
, Supplemental Digital Content 3 and 5, respectively). Further-
ore,weobservedastatisticallymarginal interactionbetweenRHR
nd ﬁsh intake in the risk of cardiovascular mortality (p=0.046),
ut not between RHR and the intake of -linolenic acid or other
utritional parameters (data not shown).
iscussion
In this 24-year prospective study of a representative Japanese
eneral population without known cardiovascular diseases and
nti-hypertensive medications, the elevated risk of cardiovascu-
ar mortality associated with increased RHR was attenuated by a
igher dietary intake of LCn3FAs, which remained after adjustment
or possible confounding factors. This association persisted in sen-
itivity analyses. To the best of our knowledge, this is the ﬁrst study
o show a signiﬁcant interaction between dietary LCn3FAs intake
nd RHR in the risk of cardiovascular mortality.
In the high-intake group of LCn3FAs, increased RHR was
ot associated with an elevated risk of cardiovascular mortality.
otably, the consumption of ﬁsh (63.8 g/1000kcal: 135.3 g/day)
nd LCn3FAs (0.59%kcal: 1.38 g/day) in the high-intake group was
arkedly higher than that of most Western populations [20].
ccordingly, our ﬁndings that cardiovascular mortality associ-
ted with an increased RHR was attenuated by a higher dietary
ntake of LCn3FAs may not be observed in Western countries. This
ommunity-based Japanese population with a remarkably higher
Cn3FAs consumption than that worldwide is the ideal cohort in
hich investigation for cardioprotective evidence of LCn3FAs can
xtend to much higher ranges of LCn3FAs intake.
Consistent with previous studies [32,33], in the current study,
ncreased RHR was associated with an elevated risk of metabolic
bnormalities, includinghyperglycemiaandhypercholesterolemia,
ost likely via high sympathetic tone. The Japan EPA lipid inter-
ention study (JELIS) reported that EPA treatment reduces the risk
f major coronary events for patients with abnormal metabolic
roﬁles more than for those without abnormal metabolic proﬁles
34,35]. LCn3FAs may affect the cardiovascular system in a favor-
ble manner, particularly when there is a disturbance in glucose or
ipid metabolism as RHR increases.
In the low-intake LCn3FAs group in our study, increased RHR
as associated with a higher risk of stroke mortality, but not
ardiac mortality. This observation is not surprising. In the Asia-
aciﬁc region, the association between increased RHR and stroke is
tronger than that between increased RHR and coronary heart dis-
ases [36]. Moreover, the incidence and mortality rate from stroke
re higher than those from myocardial infarction in Japan [37,38].
n fact, in our study, there weremore deaths from stroke than from
oronary heart diseases. Such characteristics of our study popula-
ionmayexplainwhyan increased riskbyhigherRHRwasobserved
or stroke, but not for cardiac diseases.
In our study, there were no signiﬁcant differences in RHR
etween categories of dietary LCn3FAs intake. Intake of n-3 fatty
cids, particularly from ﬁsh oil, can contribute to a reduction in
eart rate in a dose-dependent fashion, although additional effects
ppear small at higher levels of intake [11]. Even in the low-intake
roups of our study, the mean value of LCn3FAs intake (0.24%kcal:
.58 g/day) was equivalent to required and acceptable levels for
Cn3FAs [39,40]. However, the exact mechanisms of no signiﬁcant
ifference in the RHR between high- and low-intake groups remain
nclear and deserve further investigation.diology 64 (2014) 218–224
The strengths of our study include its prospective design and
24-year follow-up of participants of the national circulatory and
nutritional surveys from randomly selected health districts in
Japan. Our dietary assessment using weighed food records during
3 days also appears to be well suited for a large-scale prospective
study, in which a broad evaluation of diet is usually desirable [41].
Although recent meta-analysis, including 20 randomized clinical
trials, the majority of which were short-term studies ranging from
1 to 6.2 years, reported that n-3 fatty acids supplementation was
not associated with a lower risk of cardiovascular diseases [42],
we observed a long-term effect of dietary LCn3FAs intake against
the cardiovascular risk by increased RHR. Furthermore, although
RHR is a highly variable cardiovascular parameter because of the
effects of physical, psychological, and environmental factors, our
standardized measurement for RHR, assessed by electrocardiogra-
phy, is more accurate than pulse palpitation for a reliable estimate
[1].
There are some limitations to our ﬁndings. First, our analy-
ses were based on a single baseline measurement and may not
have accurately reﬂected long-term LCn3FAs intake and RHR in
the follow-up period. Our analyses were also limited to the gen-
eral population without known cardiovascular disease, and our
results should not be generalized to patients with various cardio-
vascular diseases. Finally, although we carefully controlled for the
majorknownconfoundersand intakeofother fattyacids,wecannot
deny the possibility of residual confounding by other unmeasured
dietary and/or lifestyle factors, suchasmental stress, physical activ-
ity, pulmonary disease, and hormonal function.
We used mortality data as endpoints, which might have led
to misclassiﬁcation of the causes of death. However, it has been
reported that the death-certiﬁcate diagnosis of stroke in Japan is
quite accurate [43]. Furthermore, mortality statistics for coronary
heart disease by the end of 1994 may have been underestimated
using the ICD9, because deaths coded as “heart failure” may hide
certain coronary events [44]. However, in our study, we addressed
those problems by death fromall heart diseases by classifying them
as “cardiac mortality”.
In conclusion, in this long-termprospectiveobservationof a rep-
resentative sample of the Japanese general population, the risk of
cardiovascularmortality associatedwith increased RHR is elevated
in participants with low dietary LCn3FAs intake, but not in partici-
pants with high dietary LCn3FAs intake. These results suggest that
high dietary LCn3FAs intake may prevent cardiovascular mortality
associated with increased RHR as a primary prevention. Whether
thepredictive role of increasedRHRon cardiovascular diseases rep-
resents a causal relationship remains unclear, although it should
not detract from the concept of RHR as a simple predictor of car-
diovascular risk [36]. If our observed association is indeed causal, a
higher intake of LCn3FAs by eating more ﬁsh may be a useful, low-
cost intervention in primary prevention for the apparently healthy
general population with a higher RHR.
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